Back to News
Market Impact: 0.6

Tate & Lyle looks to showcase growth ambitions post-CP Kelco deal

TATEDB
M&A & RestructuringCompany FundamentalsAnalyst InsightsConsumer Demand & RetailProduct LaunchesHealthcare & Biotech
Tate & Lyle looks to showcase growth ambitions post-CP Kelco deal

Deutsche Bank maintains a 'buy' rating on Tate & Lyle PLC with an 800p price target ahead of its July 1st Capital Markets Event, where management is expected to detail growth strategies following the CP Kelco acquisition. The event will focus on how CP Kelco strengthens Tate & Lyle's position in texturants and plant-based thickeners, aligning with health, wellness, and sugar reduction trends. Investors will also get an inside look at Tate & Lyle's innovation labs and pectin facility in Denmark on July 3rd, as the company aims to demonstrate its shift towards a growth-oriented strategy.

Analysis

Tate & Lyle PLC is set to detail its strategic growth initiatives, particularly following the acquisition of CP Kelco, at its Capital Markets Event on July 1st. Deutsche Bank has reiterated a 'buy' rating on the stock with an 800p price target, a significant premium to the current trading price of 544.5p, indicating considerable potential upside. The event is anticipated to showcase how the CP Kelco deal enhances Tate & Lyle's product offering in high-demand areas such as texturants, including pectin and other plant-based thickeners, which are increasingly vital for clean-label and health-conscious food formulations. Management is also expected to elaborate on how advancements in 'mouthfeel' technology are translating into new business opportunities and enabling the company to adapt to evolving consumer preferences for health, wellness, and sugar reduction. An investor visit to the company's Danish innovation labs and pectin facility on July 3rd will further underscore these ambitions. This strategic pivot, from restructuring to a more assertive growth phase, is viewed positively, as reflected by the strongly positive sentiment score of 0.85 for Tate & Lyle.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.